Health

Sanofi Launches Inhaled Insulin for Diabetics

  (CNBC) – Sanofi launched an inhalable insulin in the United States on Tuesday in a potential boost for its flagging diabetes drug sales and for patient quality of life. Developed by Mannkind, Afrezza will be the only inhalable insulin on the U.S. market, where Sanofi competes with Eli Read More

Advertisements